There are many key take away messages from the excellent management and governance of the US-CDC in relation to the Thrombosis Thrombocytopenia Syndrome (TTS) aka blood clots, associated with the viral vector-based Covid-19 vaccine from Johnson and Johnson (J&J).
1. The proactive action of the CDC and FDA to pause the use of the J&J vaccine, following reports of six cases (one fatal) of cerebral venous sinus thrombosis (CVST) with thrombocytopenia on April 13 and promptly issued a health alert.
2. The Advisory Committee on Immunisation Practices (ACIP) meeting the following day, again illustrates a sense of urgency to investigate this association of the J&J vaccine with the TTS…
Read more: https://www.malaysiakini.com/columns/572084
